On January 29, 2021, the State Food and Drug Administration issued a notice, Haikou Pharmaceutical Co., LTD. Amoxicillin capsules (0.25g) successfully approved! The "one-stop" clinical study of this variety was completed by Duzheng Biology (changsha Central Hospital, the cooperative co-construction unit, was responsible for the clinical study, Serong Intelligence was responsible for recruitment, Leading Medicine was responsible for SMO service, and weights and ke data execution data management and statistical analysis). The inspection, which clinical trial institutions and analysis testing units are exempt from inspection, fully affirmed the national Food and Drug Administration of Changsha city central hospital and are biological accreditation. 

Amoxicillin capsule is commonly used oral β -lactam anti-infection drugs, used for the treatment of bacteria caused by different parts of the infection (adults and children), such as streptococcus haemolyticus, Streptococcus pneumoniae, staphylococcus or haemophilus influenzae caused by otitis media, sinusitis, pharyngitis, tonsillitis and other upper respiratory tract infections; Urinary and reproductive infections caused by Escherichia coli, Proteus mirabilis or Enterococcus faecalis; Skin and soft tissue infection caused by streptococcus haemolyticus, Staphylococcus or Escherichia coli; Streptococcus hemolyticus, streptococcus pneumoniae, staphylococcus or haemophilus influenzae caused by acute bronchitis, pneumonia and other lower respiratory tract infections. 

Duzheng Biotech provides one-stop service for clinical research of innovative and generic drugs, and has helped numerous pharmaceutical companies obtain successful approvals！